Amide and alpha-keto carbonyl inhibitors of thrombin based on arginine and lysine: synthesis, stability and biological characterization. 1995

S F Brady, and J T Sisko, and K J Stauffer, and C D Colton, and H Qiu, and S D Lewis, and A S Ng, and J A Shafer, and M J Bogusky, and D F Veber
Department of Medicinal Chemistry, Merck Research Laboratories, West Point, PA 19486, USA.

We report structure-activity investigations in a series of tripeptide amide inhibitors of thrombin, and the development of a series of highly potent active site directed alpha-keto carbonyl inhibitors having the side chain of lysine at P1. Compounds of this class are unstable by virtue of reactivity at the electrophilic carbonyl and racemization at the adjacent carbon (CH). Modifications of prototype alpha-keto-ester 8a have afforded analogs retaining nanomolar Ki. Optimal potency and stability have been realized in alpha-keto-amides 11b (Ki = 2.8 nM) and 11c (Ki = 0.25 nM).

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D007659 Ketones Organic compounds containing a carbonyl group Ketone
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D002264 Carboxylic Acids Organic compounds containing the carboxy group (-COOH). This group of compounds includes amino acids and fatty acids. Carboxylic acids can be saturated, unsaturated, or aromatic. Carboxylic Acid,Acid, Carboxylic,Acids, Carboxylic
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein

Related Publications

S F Brady, and J T Sisko, and K J Stauffer, and C D Colton, and H Qiu, and S D Lewis, and A S Ng, and J A Shafer, and M J Bogusky, and D F Veber
January 1995, Journal of enzyme inhibition,
S F Brady, and J T Sisko, and K J Stauffer, and C D Colton, and H Qiu, and S D Lewis, and A S Ng, and J A Shafer, and M J Bogusky, and D F Veber
June 2001, Bioorganic & medicinal chemistry letters,
S F Brady, and J T Sisko, and K J Stauffer, and C D Colton, and H Qiu, and S D Lewis, and A S Ng, and J A Shafer, and M J Bogusky, and D F Veber
August 1980, Journal of medicinal chemistry,
S F Brady, and J T Sisko, and K J Stauffer, and C D Colton, and H Qiu, and S D Lewis, and A S Ng, and J A Shafer, and M J Bogusky, and D F Veber
February 1992, Journal of medicinal chemistry,
S F Brady, and J T Sisko, and K J Stauffer, and C D Colton, and H Qiu, and S D Lewis, and A S Ng, and J A Shafer, and M J Bogusky, and D F Veber
March 1996, Protein science : a publication of the Protein Society,
S F Brady, and J T Sisko, and K J Stauffer, and C D Colton, and H Qiu, and S D Lewis, and A S Ng, and J A Shafer, and M J Bogusky, and D F Veber
February 1954, The Journal of biological chemistry,
S F Brady, and J T Sisko, and K J Stauffer, and C D Colton, and H Qiu, and S D Lewis, and A S Ng, and J A Shafer, and M J Bogusky, and D F Veber
December 1980, Journal of medicinal chemistry,
S F Brady, and J T Sisko, and K J Stauffer, and C D Colton, and H Qiu, and S D Lewis, and A S Ng, and J A Shafer, and M J Bogusky, and D F Veber
October 1993, Journal of medicinal chemistry,
S F Brady, and J T Sisko, and K J Stauffer, and C D Colton, and H Qiu, and S D Lewis, and A S Ng, and J A Shafer, and M J Bogusky, and D F Veber
July 2001, Bioorganic & medicinal chemistry letters,
S F Brady, and J T Sisko, and K J Stauffer, and C D Colton, and H Qiu, and S D Lewis, and A S Ng, and J A Shafer, and M J Bogusky, and D F Veber
August 2007, Organic & biomolecular chemistry,
Copied contents to your clipboard!